Post Detail


Donald Trump became the first US president in history to be impeached twice on Wednesday, when 232 members of the House — including 10 Republicans who bucked party lines — voted in favor of impeaching the president for inciting last week's riot at the US Capitol building. Trump now faces a trial in the Senate, and if convicted, will be barred from ever holding federal office again.

Trump Weighs Many Pardons as Presidency Winds Down

President expected to issue as many as 100 pardons and commutations, but leans against some controversial grants at urging of advisers

Paris and Milan Have That New Car Company Smell

Fiat Chrysler and PSA Group, the maker of Peugeot and Citröen cars, completed their merger on Saturday, creating a brand new car company. The combo was first announced in October 2019, but Covid slowed down the i-dotting and t-crossing.


Live Stream

Timestamps in video description


Research / Recap / Additional Video

I know we're still having lag. Tomorrow ISP2 will be live so hopefully that will fix it!


No. 1: Bakkt SPAC Merger News

No. 2: Lucid Motors SPAC Merger News




Ceragon Networks Ltd.
Technology | Communication Equipment | Israel

67% 255mc 61f

Jan 15th No company specific news

Jan-13-21 06:00AM  
Jan-05-21 11:40AM  



Inuvo, Inc.
Communication Services | Advertising Agencies | USA

46% 66mc 88f

No New News..

Jan-14-21 08:30AM  



ENDRA Life Sciences Inc.
Healthcare | Diagnostics & Research | USA

46% 34mc 23f

No New News..

Jan-13-21 09:00AM  
Jan-08-21 09:00AM  


Gritstone Oncology, Inc.
Healthcare | Biotechnology | USA

45% 250mc 10f

Jan-19-21 06:00AM  
Jan-11-21 08:00AM  
Dec-28-20 08:00AM  


TransEnterix, Inc.
Healthcare | Medical Devices | USA

30% 200mc 96f

Jan-19-21 06:55AM  
Jan-14-21 02:23PM  


Tenax Therapeutics, Inc.
Healthcare | Biotechnology | USA

60% 22mc 11f

Jan-19-21 07:45AM  


Aclaris Therapeutics, Inc.
Healthcare | Biotechnology | USA

60% 260mc 37f

Jan-19-21 07:00AM  


Minerva Neurosciences, Inc.
Healthcare | Biotechnology | USA

40% 115mc 41f

January 19, 2021 08:03 AM ET (BZ Newswire) -- Biotech

WALTHAM, Mass. and NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV) and Royalty Pharma plc (NASDAQ:RPRX) today announced that Royalty Pharma will acquire Minerva's royalty interest in seltorexant for an upfront payment of $60 million and up to $95 million in additional milestone payments. The additional payments to Minerva will be contingent on the achievement of certain clinical, regulatory and commercialization milestones

Jan-19-21 06:20AM  
Jan-18-21 11:15PM  





Free Gap Scanner + Win 2 Free Stocks πŸŽ‰ (Each Up To $1600) πŸ‘‰πŸ‘‰

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER πŸ‘‰πŸ‘‰

Watchlist πŸ‘‰πŸ‘‰


Back to the post list  ⋅  0 comments have been posted.

Sample Toast 11 mins ago
tradejournal test feature